Federico Gatto Selected Research

Federico Gatto Research Topics

Disease

17	Pituitary Neoplasms (Pituitary Adenoma) 01/2024 - 04/2007
16	Acromegaly 02/2024 - 01/2013
16	Neoplasms (Cancer) 01/2024 - 01/2010
11	Adenoma (Adenomas) 02/2019 - 06/2011
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2022 - 12/2011
4	Growth Hormone-Secreting Pituitary Adenoma 09/2022 - 01/2017
3	Hypopituitarism (Sheehan's Syndrome) 01/2020 - 10/2015
2	Hyperthyroidism 01/2024 - 06/2011
2	Cushing Syndrome 12/2023 - 01/2010
2	Pituitary ACTH Hypersecretion 01/2020 - 02/2019
2	ACTH-Secreting Pituitary Adenoma 01/2020 - 02/2019
2	Prolactinoma (Prolactinomas) 01/2019 - 12/2013
1	COVID-19 04/2024
1	Atrial Fibrillation 04/2024
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2024
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2024
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 05/2023
1	Agenesis of Corpus Callosum 01/2023
1	Hyponatremia 01/2023
1	Hypothyroidism 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Chronic Disease (Chronic Diseases) 12/2020
1	Insulinoma 11/2020
1	Type 2 Diabetes Mellitus (MODY) 03/2020
1	Headache (Headaches) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Meningioma (Meningiomas) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Diabetes Insipidus 01/2020
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020
1	Craniopharyngioma (Craniopharyngiomas) 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Pathologic Constriction (Stenosis) 01/2018
1	Carcinogenesis 01/2014
1	Infections 01/2014
1	Inflammation (Inflammations) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 02/2010

Drug/Important Bio-Agent (IBA)

18	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2024 - 04/2007
18	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2023 - 04/2007
12	Growth Hormone (Somatotropin)IBA 02/2024 - 03/2016
9	LigandsIBA 01/2024 - 02/2017
8	Octreotide (Sandostatin)FDA LinkGeneric 04/2024 - 06/2011
6	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 04/2007
5	Messenger RNA (mRNA)IBA 01/2023 - 12/2013
5	pasireotideIBA 04/2021 - 01/2017
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2024 - 06/2011
4	ArrestinsIBA 01/2024 - 12/2013
4	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 03/2016
4	Hormones (Hormone)IBA 01/2020 - 04/2007
3	Insulin (Novolin)FDA Link 02/2024 - 03/2016
3	ProlactinIBA 01/2023 - 02/2015
3	Insulin-Like PeptidesIBA 12/2020 - 05/2016
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2020 - 01/2019
3	ArrestinIBA 01/2020 - 12/2013
2	Thyroid HormonesIBA 04/2024 - 06/2011
2	GlucocorticoidsIBA 12/2023 - 01/2020
2	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2023 - 01/2010
2	Cabergoline FDA LinkGeneric 01/2023 - 06/2011
2	SodiumIBA 01/2023 - 01/2020
2	Dopamine Agents (Dopaminergic Agents)IBA 01/2019 - 04/2007
2	Proteins (Proteins, Gene)FDA Link 05/2016 - 01/2013
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2013 - 01/2010
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2011 - 06/2011
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2010 - 05/2009
1	Anabolic AgentsIBA 02/2024
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2024
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2024
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 05/2023
1	Tolvaptan FDA Link 01/2023
1	somatostatin receptor 2IBA 11/2022
1	ParaffinIBA 09/2022
1	Formaldehyde (Formol)FDA Link 09/2022
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 09/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Axitinib (AG 013736)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	EnzymesIBA 01/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Diazoxide (Hyperstat)FDA Link 11/2020
1	IncretinsIBA 03/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	3,3'- dioactadecyl- 5,5'- di(4- sulfophenyl)oxacarbocyanineIBA 08/2017
1	enhanced green fluorescent proteinIBA 08/2017
1	pegvisomant FDA LinkGeneric 01/2017
1	Pituitary HormonesIBA 01/2017
1	NestinIBA 01/2017
1	beta-ArrestinsIBA 05/2016
1	ChemokinesIBA 01/2014
1	beta-Arrestin 1IBA 12/2013
1	G-Protein-Coupled Receptor Kinase 2IBA 12/2013
1	Monoclonal AntibodiesIBA 01/2013

Therapy/Procedure

22	Therapeutics 04/2024 - 04/2007
2	Radiotherapy 01/2020 - 02/2015
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2022
1	Combined Modality Therapy 01/2021